Verano Holdings VRNO
OTC VRNO
$6.21 +0.16 (+2.64%)
As of: Aug 21, 2026 · 3:59 PM EDT

Verano Holdings (VRNO) Amortization of Deferred Charges (2021 - 2026)

Verano Holdings (VRNO) posted quarterly Amortization of Deferred Charges of $3.0 million for Q1 2026, up 1.52% year-over-year from $3.0 million in Q1 2025, and little changed quarter-over-quarter from $3.0 million in Q4 2025.

Verano Holdings (VRNO) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has reported Amortization of Deferred Charges for 6 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges rose 1.52% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $12.0 million (up 7.2% YoY), while the FY2025 annual figure was $12.0 million, up 7.1% from the prior year.
  • Amortization of Deferred Charges was little changed at $3.0 million in Q1 2026 per VRNO's latest filing, from $3.0 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $3.9 million in Q2 2024 and bottomed at $1.5 million in Q1 2022.
  • Historically, Amortization of Deferred Charges has averaged $2.7 million across 5 years, with a median of $2.7 million in 2023.
  • Annual changes were most pronounced in 2022 — Amortization of Deferred Charges surged 167.88% — and 2024, when it tumbled 34.9%.
  • Verano Holdings' Amortization of Deferred Charges stood at $2.5 million in 2022, then advanced by 7.64% to $2.7 million in 2023, then sank by 34.9% to $1.7 million in 2024, then surged by 74.5% to $3.0 million in 2025, then dropped by 0.46% to $3.0 million in 2026.
  • Business Quant data shows VRNO's Amortization of Deferred Charges at $3.0 million in Q1 2026, $3.0 million in Q4 2025, and $3.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Verano Holdings 449.04 Mn 363.85 Mn 99.70 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.09 Mn
Jun 30, 2026 3.09 Mn
Mar 31, 2026 3.01 Mn
Mar 31, 2026 3.01 Mn
Dec 31, 2025 3.02 Mn
Dec 31, 2025 3.02 Mn
Sep 30, 2025 3.00 Mn
Sep 30, 2025 3.00 Mn
Jun 30, 2025 3.01 Mn
Jun 30, 2025 3.01 Mn
Mar 31, 2025 2.97 Mn
Mar 31, 2025 2.97 Mn
Dec 31, 2024 1.73 Mn
Dec 31, 2024 1.73 Mn
Sep 30, 2024 2.65 Mn
Sep 30, 2024 2.65 Mn
Jun 30, 2024 3.88 Mn
Jun 30, 2024 3.88 Mn
Mar 31, 2024 2.93 Mn
Mar 31, 2024 2.93 Mn